{
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The iShares MSCI Japan ESG Screened UCITS ETF is classified as non-complex under MiFID II based on the following analysis:1. **Replication Method**: The fund uses physical replication ('optimising techniques' mentioned in the KIID are standard for physical ETFs and do not imply synthetic replication). The fact sheet explicitly states 'Product Structure: Physical'.2. **Derivative Usage**: The KIID mentions limited use of financial derivative instruments (FDIs) for optimisation, but this is typical for physical ETFs to manage tracking error and does not indicate synthetic replication or leverage. The PRIIPs KID and fact sheet do not mention swaps or counterparty risk beyond standard disclosures.3. **Leverage/Inverse**: No references to leverage, inverse exposure, or amplified returns. The fund tracks a standard equity index with no gearing.4. **Underlying Assets**: The fund invests in liquid, large/mid-cap Japanese equities with ESG screening. No complex assets like CoCos, AT1 bonds, or CLOs are mentioned.5. **Risk Profile**: The risk rating is 6/7, which is typical for equity ETFs and does not trigger complexity. The main risks are standard equity risks (market volatility, concentration risk) with no complex derivative-related risks.6. **Counterparty Risk**: While counterparty risk is disclosed (as required for all ETFs), it is not a significant factor here due to the physical replication structure and lack of swap exposure.7. **Costs**: Simple fee structure (0.15% TER) with no performance fees or complex fee arrangements.The fund's structure is transparent, with holdings listed in the fact sheet and a straightforward equity index strategy. The ESG screening does not add complexity under MiFID II, as it is a standard exclusionary approach.**Counter-Argument Consideration**: Some might argue that the 'optimising techniques' could imply derivative usage beyond EPM, but the fact sheet's 'Product Structure: Physical' and lack of swap/counterparty risk details in the PRIIPs KID confirm this is not a synthetic ETF. The limited FDI usage is consistent with physical replication best practices.**Confidence**: 95% - The documentation consistently supports a non-complex classification, with no red flags for synthetic replication, leverage, or complex underlying assets.",
    "confidence": 95
}